Fig. 4From: Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancerCumulative incidence of the patients who eternally discontinued durvalumab due to radiation pneumonitisBack to article page